# Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma

> **NCT02141100** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Kjeld Schmiegelow**

## Conditions studied

- Non-Hodgkin Lymphoma

## Interventions

- **DRUG:** 6-thioguanine

## Key facts

- **NCT ID:** NCT02141100
- **Lead sponsor:** Kjeld Schmiegelow
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-07
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-10-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02141100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02141100, "Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02141100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*